Anne Cooper
Impact in
- Hepatology top 5%
- Liver Diseases and Immunity
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 11
- Drug Transport and Resistance Mechanisms 6
- Chemokine receptors and signaling 4
- Co-authors
- Ken Grime (3 shared papers)Rolland E. Dickson (2 shared papers)Ross L. Coppel (2 shared papers)Charles D. Surh (2 shared papers)Barry H. Hirst (2 shared papers)Douglas Ferguson (1 shared paper)Vanessa Moore (1 shared paper)Dean J. Danner (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (5 papers)Drug Metabolism and Disposition (3 papers)Current Drug Metabolism (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Hepatology (1 paper)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Anne Cooper
20 papers receiving 707 citations
Peers
Comparison fields: 5 of 78
- Hepatology 167
- Oncology 204
- Pharmacology 65
- Epidemiology 146
- Pharmaceutical Science 24
Countries citing papers authored by Anne Cooper
This map shows the geographic impact of Anne Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Cooper more than expected).
Fields of papers citing papers by Anne Cooper
This network shows the impact of papers produced by Anne Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Cooper. The network helps show where Anne Cooper may publish in the future.
Co-authors
The 25 scholars most cited alongside Anne Cooper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 161 | |
| 2 | 2004 | 116 | |
| 3 | 2012 | 79 | |
| 4 | 2004 | 70 | |
| 5 | 1988 | 54 | |
| 6 | 2005 | 44 | |
| 7 | 2012 | 33 | |
| 8 | 2003 | 31 | |
| 9 | 2002 | 24 | |
| 10 | 2005 | 21 | |
| 11 | 2010 | 20 | |
| 12 | 2004 | 20 | |
| 13 | 2006 | 15 | |
| 14 | 2013 | 10 | |
| 15 | 1990 | 7 | |
| 16 | 2012 | 5 | |
| 17 | 1996 | 5 | |
| 18 | 1995 | 5 | |
| 19 | 2021 | 4 | |
| 20 | 2012 | 3 |
About Anne Cooper
Anne Cooper is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Immunology and Pediatrics, Perinatology and Child Health, having authored 20 papers that have together received 727 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (6 papers), Chemokine receptors and signaling (4 papers), Inhalation and Respiratory Drug Delivery (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Immunotherapy and Immune Responses (3 papers), Liver Disease Diagnosis and Treatment (2 papers), Immune Cell Function and Interaction (2 papers) and Liver Diseases and Immunity (2 papers). The work is most often cited by research in Hepatology (167 citations), Oncology (204 citations), Pharmacology (65 citations), Epidemiology (146 citations) and Pharmaceutical Science (24 citations). Anne Cooper has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Ken Grime, Rolland E. Dickson, Ross L. Coppel, Charles D. Surh, Barry H. Hirst, Douglas Ferguson, Vanessa Moore, Dean J. Danner, M. Eric Gershwin and Judy Van de Water. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Drug Metabolism and Disposition, Current Drug Metabolism, Journal of Pharmacology and Experimental Therapeutics and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.